Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

5.10p
   
  • Change Today:
    -0.050p
  • 52 Week High: 11.33
  • 52 Week Low: 4.68
  • Currency: UK Pounds
  • Shares Issued: 274.89m
  • Volume: 239,485
  • Market Cap: 14.02m
  • RiskGrade: 304
  • Beta: 0.08

Evgen Pharma Overview

Evgen Pharma is in the pharma and biotech sector and is currently trading at 5.10p per share. In the last year Evgen Pharma's share price has ranged from 4.68p to 11.33p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1689.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 74.5 n/a
Pr/Book 1.2  
Latest F'cast
Revenue n/a -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Evgen Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-17 n/a (3.64) (4.13)p n/a n/a n/a n/a 0.0%
31-Mar-18 n/a (3.03) (3.23)p n/a n/a n/a n/a 0.0%
31-Mar-19 n/a (3.12) (2.70)p n/a n/a n/a n/a 0.0%
31-Mar-20 n/a (3.17) (2.07)p n/a n/a n/a n/a 0.0%
31-Mar-21 0.19 (3.21) (1.82)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Evgen Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-22 n/a (5.10) (1.50)p n/a n/a n/a n/a 0.0%
31-Mar-23 n/a (5.60) (1.70)p n/a n/a n/a n/a 0.0%
31-Mar-24 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Evgen Pharma Company Announcements

Option over new sulforaphane analogues 18-Jan-2022 07:00 RNS
Progress with UK and US regulators for 2022 trials 11-Jan-2022 07:00 RNS
Holding(s) in Company 30-Dec-2021 11:35 RNS

Latest Evgen Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 5.10p
Change Today -0.050p
% Change -0.97 %
52 Week High 11.33
52 Week Low 4.68
Volume 239,485
Shares Issued 274.89m
Market Cap 14.02m
Beta 0.08
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.41% below the market average8.41% below the market average8.41% below the market average8.41% below the market average8.41% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for 19-Jan-2022

Time Volume / Share Price
10:31 119,285 @ 5.03p
10:31 120,200 @ 5.00p

Evgen Pharma Key Personnel

CFO Richard Moulson
CEO Huw Jones

Top of Page